Effects of Phospholipid-Coated Extracorporeal Circuits on Clinical Outcome Parameters and Systemic Inflammatory Response in Coronary Artery Bypass Graft Patients


  • Christina Schulz
  • Anita Pritisanac
  • Albert Schütz
  • Erich Kilger
  • Helmut Platzer
  • Bruno Reichart
  • Stephen M. Wildhirt




Introduction: The use of extracorporeal circulation (ECC) during coronary artery bypass graft (CABG) surgery is associated with a systemic inflammatory response due to the contact of blood with artificial surfaces. The clinical relevance of ECC-related systemic inflammation varies with the patient, and such inflammation may be accompanied by intermittent organ dysfunction and an increased catecholamine requirement. We investigated the effects of a new phospholipid coating system of ECC on systemic inflammatory response and clinical outcome following CABG.

Methods: Patients scheduled for CABG surgery were prospectively divided randomly into 2 patient groups: patients using noncoated ECC materials and patients using phospholipid-coated ECC materials. Clinical data measured perioperatively included hemodynamics, aortic clamp time, duration of bypass, time to extubation, catecholamine requirement, length of intensive care unit (ICU) stay, postoperative blood loss, and amount of blood transfused. In addition, blood samples were collected before cannulation and at 2, 24, and 48 hours postoperative. Cytokines (tumor necrosis factor 3 [TNF-3] and interleukin 10 [IL-10]) and P-selectin were measured with an enzyme-linked immunosorbent assay. Plasma nitrate/nitrite levels (NOx) were determined by the Griess reaction.

Results: A significant increase of TNF-3 level was noted in the uncoated control group only. In the uncoated group, IL-10 levels significantly increased at 2 hours postoperative, whereas levels remained unchanged in the phospholipid coating group. P-selectin increased 2 hours postoperative in the uncoated group, and no significant changes were noted in the phospholipid coating group. At 24 hours postoperative, total plasma NOx production significantly increased in the phospholipid coating group but remained constant in the control group. No significant differences with respect to postoperative parameters (time to extubation, ICU stay, amount of bleeding, blood transfused, and catecholamine requirement) were observed.

Conclusions: Phospholipid coating significantly reduces the systemic increase in proinflammatory and anti-inflammatory cytokines and P-selectin. Despite the comparable clinical outcomes in this study, the observed significant reduction in systemic inflammatory parameter values suggests an improved biocompatibility of ECC materials when they are coated with phospholipids.


Op den Kamp J. 1979. Lipid asymmetry in membranes. Ann Rev Biochem 48:47-71.nPenttila H, Lepojarvi M, Kiviluoma K, Kaukoranta P, Hassinen I, Peuhkurinen K. 2001. Myocardial preservation during coronary surgery with and without cardiopulmonary bypass. Ann Thorac Surg 71:565-71.nRidker P, Buring J, Rifai N. 2001. Soluble P-selectin and risk for future events. Circulation 103:491-5.nScherphof G, Van Leeuwen B, Wilschut J, Damen J. 1983. Exchange of phosphatidylcholine between small unilamellar liposomes and human plasma high-density lipoprotein involves exclusively the phospholipid in the outer monolayer of the liposomal membrane. Biochim Biophys Acta 732:595-9.nSteinberg J, Kapelanski D, Olson J, Weiler J. 1993. Cytokines and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:1008-16.nWan S, Izzat M, Lee T, Wan I, Tang N, Yim A. 1999. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 68:52-6.nWan S, LeClerc J, Vincent J. 1997. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112:676-92.nWei M, Kuukasjarvi, Laurikka J, et al. 2001. Cytokine response in low-risk coronary artery bypass surgery. Int J Angiol 10:27-30.nWildhirt S, Schulze C, Conrad N, et al. 2000. Reduced myocardial cellular damage and lipid peroxidation in off-pump versus conventional coronary artery bypass grafting. Eur J Med Res 5:222-8.nWildhirt S, Schulze C, Schulz C, et al. 2001. Systemic and cardiac adhesion molecule expression after off-pump versus conventional coronary artery bypass grafting. Shock 16(suppl):55-9.nZuo Z, Wang C, Carpenter D, et al. 2001. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation 71:686-91.nBirks EJ, Yacoub MH. 1997. The role of nitric oxide and cytokines in heart failure. Coron Artery Dis 8:389-402.nCremer J, Martin M, Redl H, et al. 1996. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 61:1714-20.nCzerny M, Baumer H, Kilo J, et al. 2000. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 17:737-42.nDe Somer F, Francois K, van Oeveren W, et al. 2000. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg 18:602-6.nDe Somer F, Van Belleghem Y, Foubert L, et al. 1999. In vivo evaluation of a phosphorylcholine coated cardiopulmonary bypass circuit. J Extra Corpor Technol 31:62-6.nDiegeler A, Doll N, Rauch T, et al. 2000. Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation 102(suppl 3):95-100.nFernando R, Chan R. 2000. Anti-inflammatory pre-treatment and the resultant effects of interleukin-10: adjuncts to multi-therapeutical strategies. Perfusion 15:501-5.nFerrari R, Bachetti T, Confortini R, et al. 1995. Tumor necrosis factor soluble receptors in patients with congestive heart failure. Circulation 92:1479-86.nHayward J, Durrani A, Lu Y, Clayton C, Chapman D. 1986. Biomembranes as models for polymer surfaces, IV: ESCA analyses of a phosphorylcholine surface covalently bound to hydroxylated substrates. Biomaterials 7:252-8.nJones S, Trocha S, Lefer D. 2001. Cardioprotective actions of endogenous IL-10 are independent of iNOS. Am J Physiol Heart Circ Physiol 281:H48-52.nKapadia S. 1999. Cytokines and heart failure. Cardiol Rev 7:196-206. Lorant DE, Topham MK, Whatley MK, et al. 1993. Inflammatory roles of P-selectin. J Clin Invest 92:559-70.n



How to Cite

Schulz, C., Pritisanac, A., Schütz, A., Kilger, E., Platzer, H., Reichart, B., & Wildhirt, S. M. (2005). Effects of Phospholipid-Coated Extracorporeal Circuits on Clinical Outcome Parameters and Systemic Inflammatory Response in Coronary Artery Bypass Graft Patients. The Heart Surgery Forum, 6(1), 47-52. https://doi.org/10.1532/hsf.1095




Most read articles by the same author(s)

1 2 3 > >>